12:00 AM
Dec 16, 2013
 |  BC Week In Review  |  Company News  |  Deals

Kolltan, University of Toronto deal

The university granted Kolltan exclusive, worldwide rights to an undisclosed number of anti-stem cell factor ( SCF)...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >